Literature DB >> 28202313

The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STAT-mediated xCT expression in cancer cells.

Katja Linher-Melville1, Gurmit Singh2.   

Abstract

STAT3 and STAT5 mediate diverse cellular processes, transcriptionally regulating gene expression and interacting with cytoplasmic proteins. Their canonical activity is stimulated by cytokines/growth factors through JAK-STAT signaling. As targets of oncogenes with intrinsic tyrosine kinase activity, STAT3 and STAT5 become constitutively active in hematologic neoplasms and solid tumors, promoting cell proliferation and survival and modulating redox homeostasis. This review summarizes reactive oxygen species (ROS)-regulated STAT activation and how STATs influence ROS production. ROS-induced effects on post-translational modifications are presented, and STAT3/5-mediated regulation of xCT, a redox-sensitive target up-regulated in numerous cancers, is discussed with regard to transcriptional cross-talk.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ROS; Redox homeostasis; STAT3; STAT5; System x(c)(−); xCT

Mesh:

Substances:

Year:  2017        PMID: 28202313     DOI: 10.1016/j.mce.2017.02.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  19 in total

1.  TP53INP1 deficiency maintains murine B lymphopoiesis in aged bone marrow through redox-controlled IL-7R/STAT5 signaling.

Authors:  Bochra Zidi; Christelle Vincent-Fabert; Laurent Pouyet; Marion Seillier; Amelle Vandevelde; Prudence N'guessan; Mathilde Poplineau; Geoffrey Guittard; Stéphane J C Mancini; Estelle Duprez; Alice Carrier
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-17       Impact factor: 11.205

2.  Effects of octreotide on autophagy markers and cell viability markers related to metabolic activity in rat pituitary tumor cells.

Authors:  Giovanni Tulipano; Andrea Giustina
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

Review 3.  Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology.

Authors:  Carlota Recio; Borja Guerra; Miguel Guerra-Rodríguez; Haidée Aranda-Tavío; Patricia Martín-Rodríguez; Mercedes de Mirecki-Garrido; Yeray Brito-Casillas; José M García-Castellano; Ana Estévez-Braun; Leandro Fernández-Pérez
Journal:  Oncogene       Date:  2019-02-19       Impact factor: 9.867

4.  The antioxidant role of STAT3 in methylmercury-induced toxicity in mouse hypothalamic neuronal GT1-7 cell line.

Authors:  Beatriz Ferrer; Harshini Suresh; Abel Santamaria; João Batista Rocha; Aaron B Bowman; Michael Aschner
Journal:  Free Radic Biol Med       Date:  2021-05-16       Impact factor: 8.101

Review 5.  Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk.

Authors:  Anna L Lang; Juliane I Beier
Journal:  Biol Chem       Date:  2018-10-25       Impact factor: 4.700

Review 6.  Neocytolysis: How to Get Rid of the Extra Erythrocytes Formed by Stress Erythropoiesis Upon Descent From High Altitude.

Authors:  Heimo Mairbäurl
Journal:  Front Physiol       Date:  2018-04-05       Impact factor: 4.566

Review 7.  Nucleus, Mitochondrion, or Reticulum? STAT3 à La Carte.

Authors:  Lidia Avalle; Valeria Poli
Journal:  Int J Mol Sci       Date:  2018-09-18       Impact factor: 5.923

8.  Circular RNA hsa_circ_0001649 suppresses the growth of osteosarcoma cells via sponging multiple miRNAs.

Authors:  Deping Sun; Dongsheng Zhu
Journal:  Cell Cycle       Date:  2020-09-20       Impact factor: 4.534

9.  Functional effects of TrkA inhibition on system xC--mediated glutamate release and cancer-induced bone pain.

Authors:  Tanya Miladinovic; Robert G Ungard; Katja Linher-Melville; Snezana Popovic; Gurmit Singh
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

10.  Identification of a functional antioxidant response element at the HIF1A locus.

Authors:  Sarah E Lacher; Daniel C Levings; Samuel Freeman; Matthew Slattery
Journal:  Redox Biol       Date:  2018-08-30       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.